Henan Newland Pharmaceutical Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 31.63%

Henan Newland Pharmaceutical Co. Ltd. A (301277) has an Asset Resilience Ratio of 31.63% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 301277 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥558.53 Million

≈ $81.73 Million USD Cash + Short-term Investments

Total Assets

CN¥1.77 Billion

≈ $258.37 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Henan Newland Pharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. See Henan Newland Pharmaceutical Co. Ltd. A shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Henan Newland Pharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 301277 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥558.53 Million	31.63%
Total Liquid Assets	CN¥558.53 Million	31.63%

Asset Resilience Insights

Very High Liquidity: Henan Newland Pharmaceutical Co. Ltd. A maintains exceptional liquid asset reserves at 31.63% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Henan Newland Pharmaceutical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Henan Newland Pharmaceutical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Henan Newland Pharmaceutical Co. Ltd. A (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Henan Newland Pharmaceutical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	28.95%	CN¥525.16 Million ≈ $76.85 Million	CN¥1.81 Billion ≈ $265.41 Million	-7.67pp
2023-12-31	36.63%	CN¥589.50 Million ≈ $86.26 Million	CN¥1.61 Billion ≈ $235.52 Million	-9.10pp
2022-12-31	45.73%	CN¥701.36 Million ≈ $102.63 Million	CN¥1.53 Billion ≈ $224.44 Million	+44.43pp
2021-12-31	1.30%	CN¥8.67 Million ≈ $1.27 Million	CN¥667.90 Million ≈ $97.74 Million	--

pp = percentage points

About Henan Newland Pharmaceutical Co. Ltd. A

SHE:301277 China Drug Manufacturers - Specialty & Generic

Market Cap

$654.06 Million

CN¥4.47 Billion CNY

Market Cap Rank

#11172 Global

#3337 in China

Share Price

CN¥11.40

Change (1 day)

-1.13%

52-Week Range

CN¥10.86 - CN¥17.70

All Time High

CN¥19.48